{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:11Z","timestamp":1793860151819,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Fund of the National Natural Science Foundation of China","id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Projects of the Jiangsu Basic Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05021-5","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:14:24Z","timestamp":1776536064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic umbilical cord-derived mesenchymal stromal cells for treatment of refractory lupus nephritis: a real-world study"],"prefix":"10.1186","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct00698191","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yaru","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuman","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-0668","authenticated-orcid":false,"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-2036","authenticated-orcid":false,"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"11","key":"5021_CR1","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81\u201396.","journal-title":"Ann Intern Med"},{"issue":"2","key":"5021_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5021_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15\u201329.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5021_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40265-022-01824-x","volume":"83","author":"D Roccatello","year":"2023","unstructured":"Roccatello D, Sciascia S, Rossi D, Fenoglio R. Refractory systemic lupus erythematosus: identification and pharmacological management. Drugs. 2023;83(2):117\u201334.","journal-title":"Drugs"},{"issue":"5","key":"5021_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12(5):383\u201396.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5021_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang D, Huang S, Yuan X, et al. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5):423\u201331.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"5021_CR7","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","volume":"10","author":"X Yuan","year":"2019","unstructured":"Yuan X, Qin X, Wang D, et al. Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients. Nat Commun. 2019;10(1):2498.","journal-title":"Nat Commun"},{"issue":"10","key":"5021_CR8","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.4049\/jimmunol.1400036","volume":"193","author":"N Che","year":"2014","unstructured":"Che N, Li X, Zhang L, et al. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression. J Immunol. 2014;193(10):5306\u201314.","journal-title":"J Immunol"},{"key":"5021_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/530501","volume":"2014","author":"GP Ruan","year":"2014","unstructured":"Ruan GP, Yao X, Yang SJ, et al. Transplanted human umbilical cord mesenchymal stem cells facilitate lesion repair in B6.Fas mice. J Immunol Res. 2014;2014:530501.","journal-title":"J Immunol Res"},{"issue":"3","key":"5021_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez MA, Gonzalez-Rey E, Rico L, B\u00fcscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 2009;136(3):978\u201389.","journal-title":"Gastroenterology"},{"issue":"8","key":"5021_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69(8):1423\u20139.","journal-title":"Ann Rheum Dis"},{"key":"5021_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2021.103324","author":"A Ranjbar","year":"2022","unstructured":"Ranjbar A, Hassanzadeh H, Jahandoust F, et al. Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: results of a phase I clinical trial. Curr Res Transl Med. 2022. https:\/\/doi.org\/10.1016\/j.retram.2021.103324.","journal-title":"Curr Res Transl Med"},{"issue":"11","key":"5021_CR13","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","volume":"33","author":"F Gu","year":"2014","unstructured":"Gu F, Wang D, Zhang H, et al. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014;33(11):1611\u20139.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5021_CR14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/sctm.17-0002","volume":"6","author":"D Wang","year":"2017","unstructured":"Wang D, Wang S, Huang S, et al. Serum IFN-\u03b3 predicts the therapeutic effect of mesenchymal stem cells transplantation in systemic lupus erythematosus patients. Stem Cells Transl Med. 2017;6(9):1777\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"5021_CR15","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3727\/096368911X582769c","volume":"22","author":"D Wang","year":"2013","unstructured":"Wang D, Zhang H, Liang J, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013;22(12):2267\u201377.","journal-title":"Cell Transplant"},{"key":"5021_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"issue":"1","key":"5021_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12(1):87\u2013117.","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"5021_CR18","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar4520","volume":"16","author":"D Wang","year":"2014","unstructured":"Wang D, Li J, Zhang Y, et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res therapy. 2014;16(2):R79.","journal-title":"Arthritis Res therapy"},{"issue":"13","key":"5021_CR19","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1177\/0961203318804922","volume":"27","author":"J Barbado","year":"2018","unstructured":"Barbado J, Tabera S, S\u00e1nchez A, Garc\u00eda-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018;27(13):2161\u20135.","journal-title":"Lupus"},{"issue":"1","key":"5021_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202510","volume":"10","author":"H Chen","year":"2022","unstructured":"Chen H, Wen X, Liu S, et al. Dissecting heterogeneity reveals a unique BAMBI(high) MFGE8(high) subpopulation of human UC-MSCs. Adv Sci. 2022;10(1): e2202510.","journal-title":"Adv Sci"},{"issue":"1","key":"5021_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14(1):24.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5021_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1160\/TH10-05-0269","volume":"104","author":"Q Lian","year":"2010","unstructured":"Lian Q, Chow Y, Esteban MA, Pei D, Tse HF. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases. Thromb Haemost. 2010;104(1):39\u201344.","journal-title":"Thromb Haemost"},{"issue":"11","key":"5021_CR23","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","volume":"26","author":"AJC Bloor","year":"2020","unstructured":"Bloor AJC, Patel A, Griffin JE, et al. Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nat Med. 2020;26(11):1720\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"5021_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-020-01836-3","volume":"21","author":"A AlYousef","year":"2020","unstructured":"AlYousef A, AlSahow A, AlHelal B, et al. Glomerulonephritis histopathological pattern change. BMC Nephrol. 2020;21(1):186.","journal-title":"BMC Nephrol"},{"issue":"9","key":"5021_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","volume":"77","author":"G Moroni","year":"2018","unstructured":"Moroni G, Vercelloni PG, Quaglini S, et al. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis. 2018;77(9):1318\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"5021_CR26","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1089\/scd.2016.0326","volume":"26","author":"VC Khanh","year":"2017","unstructured":"Khanh VC, Ohneda K, Kato T, et al. Uremic toxins affect the imbalance of redox state and overexpression of prolyl hydroxylase 2 in human adipose tissue-derived mesenchymal stem cells involved in wound healing. Stem Cells Dev. 2017;26(13):948\u201363.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"5021_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13287-015-0095-0","volume":"6","author":"Y Wang","year":"2015","unstructured":"Wang Y, Lu X, He J, Zhao W. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Res Ther. 2015;6(1):100.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"5021_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10157-015-1079-1","volume":"19","author":"HC Caldas","year":"2015","unstructured":"Caldas HC, Couto TAP, Fernandes IMM, et al. Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failure. Clin Exp Nephrol. 2015;19(5):783\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"5021_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7061408","volume":"2019","author":"L Wen","year":"2019","unstructured":"Wen L, Labopin M, Badoglio M, Wang D, Sun L, Farge-Bancel D. Prognostic factors for clinical response in systemic lupus erythematosus patients treated by allogeneic mesenchymal stem cells. Stem Cells Int. 2019;2019:7061408.","journal-title":"Stem Cells Int"},{"issue":"10","key":"5021_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/ndt\/gfw289","volume":"31","author":"CC Mok","year":"2016","unstructured":"Mok CC. Pro: the use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrol Dial Transplant. 2016;31(10):1561\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"5021_CR31","doi-asserted-by":"publisher","first-page":"e78699","DOI":"10.1371\/journal.pone.0078699","volume":"8","author":"K Migita","year":"2013","unstructured":"Migita K, Arai T, Ishizuka N, et al. Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy. PLoS One. 2013;8(11):e78699.","journal-title":"PLoS One"},{"issue":"5","key":"5021_CR32","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2665-9913(23)00091-7","volume":"5","author":"M Rodziewicz","year":"2023","unstructured":"Rodziewicz M, Dyball S, Lunt M, et al. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study. Lancet Rheumatol. 2023;5(5):e284-92.","journal-title":"Lancet Rheumatol"},{"key":"5021_CR33","doi-asserted-by":"publisher","first-page":"5303048","DOI":"10.1155\/2016\/5303048","volume":"2016","author":"MT Sutton","year":"2016","unstructured":"Sutton MT, Fletcher D, Ghosh SK, et al. Antimicrobial properties of mesenchymal stem cells: therapeutic potential for cystic fibrosis infection, and treatment. Stem Cells Int. 2016;2016:5303048.","journal-title":"Stem Cells Int"},{"issue":"5","key":"5021_CR34","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with crohn\u2019s disease. Gastroenterology. 2018;154(5):1334-e13421334.","journal-title":"Gastroenterology"},{"issue":"6","key":"5021_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Multiple Scler Relat Disord. 2014;3(6):696\u2013704.","journal-title":"Multiple Scler Relat Disord"},{"issue":"7","key":"5021_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.humimm.2022.04.011","volume":"83","author":"E Roshandel","year":"2022","unstructured":"Roshandel E, Mehravar M, Dehghani Ghorbi M, Tabarraee M, Salimi M, Hajifathali A. Potential and challenges of placenta-derived decidua stromal cell therapy in inflammation-associated disorders. Hum Immunol. 2022;83(7):580\u20138.","journal-title":"Hum Immunol"},{"key":"5021_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12990","author":"B Gustafsson","year":"2017","unstructured":"Gustafsson B, Frisk P, Szakos A, Sadeghi B, Ringd\u00e9n O, Frost BM. Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life\u2010threatening acute gastrointestinal graft\u2010versus\u2010host disease. Pediatr Transplant. 2017. https:\/\/doi.org\/10.1111\/petr.12990.","journal-title":"Pediatr Transplant"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05021-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:04:36Z","timestamp":1793858676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5021"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05021-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to restore Equal Contribution to the first and last two authors.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study, \u201cAllogeneic Umbilical Cord \u2013 Derived Mesenchymal Stromal Cells for Treatment of Refractory Lupus Nephritis\u201d, was approved by the local Ethics Committee at the Drum Tower Hospital of Nanjing University Medical School on December 1, 2006. The clinical trial was registered on the Clinical Trials website under the title \u201cMesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus\u201d on March 1, 2007. The registration number is NCT00698191. Informed consent was obtained from all individual participants included in the study. Patients signed informed consent regarding publishing their data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"201"}}